BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21712776)

  • 1. Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity.
    Maes M; Galecki P; Verkerk R; Rief W
    Neuro Endocrinol Lett; 2011; 32(3):264-73. PubMed ID: 21712776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway.
    Maes M; Rief W
    Psychiatry Res; 2012 Apr; 196(2-3):243-9. PubMed ID: 22364930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.
    Kanth VR; Lavanya K; Srinivas J; Raju TN
    Curr Eye Res; 2009 Apr; 34(4):274-81. PubMed ID: 19373575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection.
    Baranyi A; Meinitzer A; Stepan A; Putz-Bankuti C; Breitenecker RJ; Stauber R; Kapfhammer HP; Rothenhäusler HB
    Psychother Psychosom; 2013; 82(5):332-40. PubMed ID: 23942342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization.
    Anderson G; Maes M; Berk M
    Adv Protein Chem Struct Biol; 2012; 88():27-48. PubMed ID: 22814705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
    Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease.
    Swardfager W; Herrmann N; Dowlati Y; Oh PI; Kiss A; Walker SE; Lanctôt KL
    Psychoneuroendocrinology; 2009 Nov; 34(10):1560-6. PubMed ID: 19540675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.
    Munipally PK; Agraharm SG; Valavala VK; Gundae S; Turlapati NR
    Arch Physiol Biochem; 2011 Dec; 117(5):254-8. PubMed ID: 22034910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
    Barry S; Clarke G; Scully P; Dinan TG
    J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity.
    Chaves Filho AJM; Lima CNC; Vasconcelos SMM; de Lucena DF; Maes M; Macedo D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):234-249. PubMed ID: 28595944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
    Myint AM; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
    Pawlowski T; Pawlak D; Inglot M; Zalewska M; Marciniak D; Bugajska J; Janocha-Litwin J; Malyszczak K
    J Psychiatry Neurosci; 2021 Jan; 46(1):E166-E175. PubMed ID: 33464780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
    Schefold JC; Zeden JP; Pschowski R; Hammoud B; Fotopoulou C; Hasper D; Fusch G; Von Haehling S; Volk HD; Meisel C; Schütt C; Reinke P
    Scand J Infect Dis; 2010 Mar; 42(3):164-71. PubMed ID: 19958238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis.
    Almulla AF; Thipakorn Y; Vasupanrajit A; Tunvirachaisakul C; Oxenkrug G; Al-Hakeim HK; Maes M
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer.
    Barreto FS; Chaves Filho AJM; de Araújo MCCR; de Moraes MO; de Moraes MEA; Maes M; de Lucena DF; Macedo DS
    Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):165-180. PubMed ID: 29543650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.